Five days per week in the field within approximately a one-hour driving radius.
Nourish provides telehealth nutrition counseling by connecting individuals with registered dietitians for personalized guidance. Sessions happen online, enabling affordable access with the aim of having insurance cover the costs. The service supports people managing health conditions—such as autoimmune diseases, diabetes, and eating disorders—as well as those pursuing general wellness. How it works: users connect with a dietitian through Nourish’s online platform, receive tailored nutrition plans, education, and ongoing support to drive long-term behavior change. Revenue likely comes from insurance partnerships or service fees for the platform. Nourish differentiates itself by focusing on insurance-covered, accessible care and sustained, education-based therapy that targets root causes of health issues rather than quick fixes. Its goal is to make professional nutrition counseling practical and affordable to support preventive healthcare and chronic condition management.
Company Size
1,001-5,000
Company Stage
Series C
Total Funding
$213.1M
Headquarters
San Francisco, California
Founded
2021
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Viome launches AI microbiome tracker for personalized gut health in Japan. Key takeaways. * Viome Life Sciences has partnered with Ezaki Glico to launch Japan's first personalized health service based on gut bacteria mRNA analysis. * The system evaluates microbial activity to generate 26 health scores and tailored nutrition guidance paired with personal consultations. * Glico aims to reach 50,000 customers by 2030 as Viome uses the partnership to expand its international presence and refine its precision AI models. US-based precision health company Viome Life Sciences, specializing in diagnostic testing and personalized nutrition recommendations, has partnered with Japanese food company Ezaki Glico to launch its mRNA Health Tracker. The platform is marketed as Japan's first personalized health service built on gut bacteria mRNA analysis. The screening system uses Viome's gut bacteria mRNA testing kits to collect microbiome data to reveal how a person's gut is functioning. According to Viome, this reveals not just which bacteria are present, but how active they are. The system translates its results into 26 personalized health scores and food recommendations. Glico's personal advisors then guide each customer toward foods, meal sets, and supplements suited to their biology in a personal consultation, with the aim of supporting healthier habits over time. "For decades, people have been told to eat 'healthy' food without anyone asking what that actually means for their body. Ezaki Glico has spent a century earning the trust of Japanese households by taking nutrition seriously," says Naveen Jain, founder and CEO of Viome. "Now, we're combining that trust with science to show each person what truly suits them. This is what it looks like when precision health intelligence meets a partner who already understands food as medicine." Glico plans to roll out this service to 50,000 customers by 2030, with a focus on test distribution and data collection for health-conscious customer cohorts this year. Translating biological data. Viome highlights its collaboration with Glico as its first international application of its partnership model, which is designed to pair Viome's precision health intelligence platform with companies that have complementary capabilities. Under this model, Viome supplies the technology and infrastructure behind the personalized health experience, testing kit logistics, RNA analysis, and proprietary AI models. Viome says that its Glico partnership demonstrates how its platform can be adapted to local markets while maintaining its underlying technology and intelligence layer.Partners bring their own strengths, such as product formulation, distribution, and additional consumer guidance. Working together, the companies translate individual biological data into "actionable products and services that improve public health on the personal level." The platform is designed to improve with longer-term use, which improves the accuracy of the model and refines health scores in aggregate, as customers act on their recommendations and return for retesting. Viome says that its Glico partnership also demonstrates how its platform can be adapted to local markets while maintaining its underlying technology and intelligence layer. "As more individuals test, act on recommendations, and retest, the resulting data helps refine Viome's models to improve the precision of the technology, a dynamic Viome expects to compound as it brings the same partnership approach to additional partners in new markets and categories," the company details. Growing global footprint. Launching the mRNA Health Tracker in Japan ties in with Viome's expanding international footprint, as the company highlights global growth in personalized, science-based approaches to nutrition and gut health. With Viome Life Sciences' proprietary AI models and RNA sequencing technology, exclusively licensed from Los Alamos National Laboratory in New Mexico, the company offers diagnostic tests and personalized nutrition plans to help individuals understand and improve their health. In other recent developments in personalized nutrition guidance, metabolic health provider Nourish launched its Nourish Labs program, which offers patients free cardiometabolic lab testing that integrates directly into ongoing care. National lab partners translate this blood work into a personalized plan patients can understand, take action on, and sustain. Meanwhile, a new Plug and Play report found that the next wave of microbiome solutions is pairing AI and big data.
Nutrition health platform Nourish featured on Inc. 5000 list 2026. The company was ranked at No. 39 based on its revenue growth over the past three years. Published on Aug. 14, 2026 Nourish, a metabolic health company headquartered in New York, was featured among the fastest-growing companies in the U.S. on the 2026 Inc. 5000 list. The company matches professionals from its network of more than 10,000 registered dietitians to patients, helping them address needs such as diabetes management and gastrointestinal issues. The company combines insurance-covered nutrition care with services such as mental health counseling and medication management. It recorded 6,794 percent revenue growth between 2022 and 2025 and recently added prescribing and managing GLP-1 medications, which are used to aid in weight loss, to its portfolio in response to customer demand. Along Nourish's growth journey, the company's co-founder and CEO Aidan Dewar had advisers through Y Combinator and worked with executive coaches, according to reporting by Inc. He also sought out founders who had already found solutions to address the same issue. "The more specific you can get, often the more value you can get," Dewar told Inc., commenting on the topic. "Who are the best people in the world at what you're trying to be great at? "Here's where I am today. How do I close that gap?"
Newsweek ranks Nourish among Greatest Startup Workplaces 2026. The company connects patients to personalized clinical nutrition care when they need it. Published on Aug. 07, 2026 Rose Velazquez Nourish, a company working to make eating well easier for people across the U.S., was recently featured on Newsweek's 2026 list of America's Greatest Startup Workplaces. The company was rated 4.5 out of five stars based on factors including employee satisfaction metrics, operational growth indicators, customer engagement and financial strength data. Newsweek initially evaluated 26,000 startups, narrowing the eligible list down to more than 2,000 based on employee headcount, headquarters location and founding year. Companies with at least 50 employees established during or after 2020 are included, though the list excludes organizations built through mergers, acquisitions or rebranding initiatives. Nourish was one of the final companies included based on several performance indicators that evaluated workplace environment, scalability, revenue potential, market traction, investor confidence and overall growth outlook.
Nourish, the largest dietitian-led metabolic health clinic in the US, has announced its Clinical Outcomes Model, which ties fees directly to patient results. The approach targets the 89% of Nourish patients with metabolic conditions through integrated care delivery, product development and data infrastructure. The model operates across four areas: clinical quality and coaching, clinical development, AI-enabled consumer technology, and data analytics. Nourish uses its Early Drivers of Outcomes framework to identify patient behaviours that predict results, enabling early intervention. The company reports a 30% year-over-year improvement in patient weight loss outcomes. After 12 months without GLP-1 medications, Nourish patients achieve an average of 8% weight loss, 1.3-point A1c reduction and 27-point LDL cholesterol reduction. The outcomes-based model is available to over 200 million Americans.
Nourish announces Clinical Outcomes Model, tying fees to performance in the first outcomes-based approach for dietitian-led metabolic care. Published: June 30, 2026 Take your first step toward a longer, healthier life. Key takeaways. * Nourish announced today the launch of the Nourish Clinical Outcomes Model, the first integrated system for continuous outcomes improvement in dietitian-led metabolic care. Spanning clinical quality, care innovation, AI-powered technology, and data infrastructure, the Model represents a company-wide mandate to ensure every Nourish patient benefits from the most effective care available. * The Model has also enabled Nourish to introduce outcomes-based partnership models that tie fees directly to the results patients achieve. For health plan and employer partners facing pressure to reduce the total cost of care, this represents a fundamental shift in how dietitian-led care is delivered. * The results are clear: patient weight loss outcomes have improved 30% year-over-year, and Nourish patients achieve an average of 8% weight loss, a 1.3-point reduction in A1c, and a 27-point reduction in LDL cholesterol after 12 months, without GLP-1s. These outcomes reflect the compounding impact of coordinated investment across clinical care, product, and data. Nourish, the country's largest dietitian-led metabolic health clinic, today announced the Nourish Clinical Outcomes Model: an integrated model across care delivery, product, and data focused on the continuous improvement of patient outcomes, both with and without medications. 89% of Nourish patients have at least one metabolic condition, among the most complex and costly conditions to treat. Driving measurable outcomes for this high-acuity population requires a coordinated investment across clinical care, product, and data infrastructure - a system that has not existed in dietitian-led care until now. The Nourish Clinical Outcomes Model operates across four interconnected levers: * Clinical quality and coaching: Clinicians have real-time visibility into patient progress against clinically relevant, condition-specific goals. This is reinforced with 1-on-1, scenario-based coaching that builds counseling fluency and outcomes-oriented clinical tactics, equipping clinicians to adapt their approaches across patient panels. * Clinical development and innovation: Condition-specific care pathways are continuously refined against the latest peer-reviewed evidence, establishing a best-in-class standard of care across the Nourish clinician network. In parallel, a robust pipeline of outcomes-targeted efforts, including routine metabolic lab panels, smart scales, and personalized patient communications, expands the modalities used to support patients between visits and accelerate their progress toward goals. * AI-enabled consumer technology: As Nourish's AI-powered platform adds new features across meal planning, between-session guidance, habit tracking, and more, each is evaluated against outcomes as a core success metric. Structured holdout groups and defined read timelines surface outcome signals within weeks of launch, enabling rapid iteration. * Data and continuous learning: One of the largest longitudinal outcomes datasets in dietitian-led care powers a continuous feedback loop between outcomes measurement and care delivery. At its core is the Early Drivers of Outcomes framework, identifying patient behaviors that predict outcomes weeks before traditional measures, allowing for early intervention and ongoing care model refinement. The Clinical Outcomes Model has enabled Nourish to better align incentives with its partners, introducing outcomes-based partnership models that tie fees directly to the results patients achieve and help reduce the total cost of care for health plans and employers. The results are clear: patient weight loss outcomes have improved 30% year-over-year, and Nourish patients achieve an average of 8% weight loss, 1.3-point reduction in A1c, and 27-point reduction in LDL cholesterol after 12 months, without GLP-1s. "Exceptional patient outcomes aren't a byproduct of what we do - they're at the center of everything we're building toward," said Aidan Dewar, Co-Founder and CEO of Nourish. "Across all Nourish teams, outcomes are the primary benchmark by which we measure success. Our confidence in this model is why we're willing to put our fees at risk for our partners." As the metabolic health crisis continues to grow, Nourish believes this model represents a new standard for what dietitian-led care can deliver. About Nourish: Nourish is the country's largest dietitian-led metabolic health clinic, building the first AI-native virtual care model to tackle America's healthcare crisis and reverse chronic disease. The company pairs 10,000+ Registered Dietitians with AI agents to deliver insurance-covered, personalized care that produces best-in-class outcomes. For patients who need access, Nourish integrates GLP-1 medication management, lab testing, and medical care into one care model designed for sustained behavior change. Through partnerships with the nation's largest health plans, health systems, and employers, Nourish is available to over 200 million Americans across all 50 states - typically at no cost. Nourish is actively hiring across clinical and business roles - learn more at nourish.com.